<DOC>
	<DOCNO>NCT00428246</DOCNO>
	<brief_summary>The study possible protective effect paricalcitol ( Zemplar ) upon inflammation , blood pressure kidney function . Kidney Inflammation occur white blood cell become abnormally stimulated accumulate kidney cause damage kidney . The purpose study determine paricalcitol help improve kidney injury , blood pressure control kidney function patient chronic kidney disease . The study last 7 week involve 8 visit medical center .</brief_summary>
	<brief_title>Study Protective Effects Paricalcitol Inner Layer Vessels Its Protective Effect Inflammation</brief_title>
	<detailed_description>We hypothesize use paricalcitol patient chronic kidney disease lead improvement oxidative stress , inflammation , endothelial function subsequently ambulatory blood pressure glomerular filtration rate . We pursue hypothesis three specific aim : Aim 1 : To compare oxidative stress marker patient treat paricalcitol study . Aim 2 : To measure endothelial function flow mediate dilation patient chronic kidney disease paricalcitol . Aim 3 : To measure actigraphy guide ambulatory blood pressure GFR absence change anti-hypertensive medication patient chronic kidney disease . The study double blind randomized pilot trial 24 patient chronic kidney disease 1:1:1 allocation paricalcitol 1 microgram : paricalcitol 2 microgram : Placebo .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Patients chronic kidney disease estimate GFR 30 mL/minute . Patients receive stable dose ACE inhibitor Angiotensin receptor blocker least one month . Patients currently hypertensive 180/110 mmHg clinic blood pressure . Hemoglobulin A1C &lt; 11 % Patients take vitamin D analog Calcium &gt; 10 mg/dL Phosphorus &gt; 6 mg/dL Patients anticipate need dialysis next 6 week Patients unstable opinion investigator Patients emergent need start IV iron Patients start statin within next 6 week Patients currently take PDE5 inhibitor Patients allergic radiocontrast , Zemplar take nitroglycerin Patients know HIV positive Patients give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Endothelial dysfunction</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Hypertension</keyword>
	<keyword>paricalcitol</keyword>
	<keyword>Blood pressure</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Glomerular filtration rate</keyword>
</DOC>